BQ-788

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBQ-788
Drug Alias NameBQ-788
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type B antagonists
TargetsEndothelin receptor type B
Therapy Area/IndicationsHypertensionCardiovascular DiseasesMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Inactive CompaniesMelcure SaMerck Serono
Active IndicationsCardiovascular Diseases
Inactive IndicationsHypertensionMelanoma

Other Information

ATC CodeN/A
Related LinksWikipedia